Dai Yuan

Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University

Affiliated withShandong Provincial Hospital Affiliated to Shandong First Medical University

Research Area

Biography

Dai Yuan has not added Biography.
If you are Dai Yuan and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2026

Other Publications

Article	Year
Altered expression of T cell Immunoglobulin-Mucin (Tim) molecules in peripheral blood mononuclear cells in aplastic anemia. Cancer cell international\| PubMed ID: 25548541	2014
Autoimmune thrombocytopenia: a complication of fludarabine therapy in the treatment of Waldenstrom's macroglobulinemia. International journal of clinical and experimental medicine\| PubMed ID: 25664138	2014
Whole exome sequencing detects CHST3 mutation in patient with acute promyelocytic leukemia: A case report. Medicine\| PubMed ID: 30200136	2018
Mutational spectrum and associations with clinical features in patients with acute myeloid leukaemia based on next‑generation sequencing. Molecular medicine reports\| PubMed ID: 30942411	2019
Rapamycin induces megakaryocytic differentiation through increasing autophagy in Dami cells. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis\| PubMed ID: 32398462	2020
Significant reductions in apoptosis-related proteins (HSPA6, HSPA8, ITGB3, YWHAH, and PRDX6) are involved in immune thrombocytopenia. Journal of thrombosis and thrombolysis\| PubMed ID: 33047245	2021
Abnormal expression of autophagy-related proteins in immune thrombocytopenia. Scandinavian journal of immunology\| PubMed ID: 33140452	2021
Reduced IL-35 in patients with immune thrombocytopenia. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis\| PubMed ID: 33141778	2020
Mucin mutations and aberrant expression are associated with the pathogenesis of immune thrombocytopenia. Thrombosis research\| PubMed ID: 33213847	2020
Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety. Frontiers in oncology\| PubMed ID: 33842312	2021
Quantitative LC-MS/MS uncovers the regulatory role of autophagy in immune thrombocytopenia. Cancer cell international\| PubMed ID: 34663331	2021
An Extended Prognostic Index of the ISSWM Score Based on Thyroid Complications in Waldenström Macroglobulinemia/Lymphoplasmacytoid Lymphoma. Frontiers in oncology\| PubMed ID: 35646661	2022
High-throughput DNA methylation analysis in ITP confirms NOTCH1 hypermethylation through the Th1 and Th2 cell differentiation pathways. International immunopharmacology\| PubMed ID: 35930913	2022
Gene mutations in the PI3K/Akt signaling pathway were related to immune thrombocytopenia pathogenesis. Medicine\| PubMed ID: 36800582	2023
Prognosis and complications of patients with primary gastrointestinal diffuse large B-cell lymphoma: Development and validation of the systemic inflammation response index-covered score. Cancer medicine\| PubMed ID: 36866830	2023
Dyslipidemia in the First 100 days and the Association with Acute Graft-versus-host Disease after Allogeneic Stem Cell Transplantation: A Single-center Retrospective Study in China. Transplant immunology\| PubMed ID: 36972854	2023
Clinicopathological characteristics and cancer-specific prognosis of primary pulmonary lymphoepithelioma-like carcinoma: a population study of the US SEER database and a Chinese hospital. Frontiers in oncology\| PubMed ID: 37274245	2023
The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends. Frontiers in oncology\| PubMed ID: 37333805	2023
Identification of ORM1, vWF, SPARC, and PPBP as immune-related proteins involved in immune thrombocytopenia by quantitative LC-MS/MS. Clinical proteomics\| PubMed ID: 37355563	2023
Serum indicators in functional high-risk multiple myeloma patients undertaking proteasome inhibitors therapy: a retrospective study. Hematology (Amsterdam, Netherlands)\| PubMed ID: 38205814	2024
Eltrombopag can promote platelet implantation after allogeneic hematopoietic stem cell transplantation as safely and similarly to thrombopoietin. Frontiers in immunology\| PubMed ID: 38650933	2024
Atypical BCR-ABL1 transcript in mixed phenotype acute leukemia with bone marrow necrosis. Molecular carcinogenesis\| PubMed ID: 38860593	2024
Umbilical cord blood stem cells as third-party adjuvant infusions in human leukocyte antigen antibody-positive patients undergoing haploidentical hematopoietic stem cell transplantation. Frontiers in immunology\| PubMed ID: 39399498	2024
Preventive hyperbaric oxygen therapy improves acute graft-versus-host disease by activating the Nrf2/HO-1 pathway. Frontiers in immunology\| PubMed ID: 40083556	2025
Exosome- transported FER inhibitor suppresses progression of diffuse large B-cell lymphoma via regulating AJUBA/Hippo axis. NPJ precision oncology\| PubMed ID: 40707658	2025